Nanobac Pharmaceuticals, Incorporated
OTC: NNBP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Stanton
- Employees
- 1
- Headquarters
- Tampa, United States
- IPO year
- 1994
- Market cap
- $25.0K
- Website
- http://www.nanobac.com
Loading NNBP…
Loading profile data…Frequently asked questions about NNBP
What does Nanobac Pharmaceuticals, Incorporated (NNBP) do?
Nanobac Pharmaceuticals, Incorporated is dedicated to advancing human health through the creation and refinement of products and services designed for the identification and management of calcifying nanoparticles (CNPs). The company's offerings include the production and sale of in vitro diagnostic (IVD) kits, which encompass assays, antibodies,...
Where does NNBP trade?
Nanobac Pharmaceuticals, Incorporated (NNBP) trades on the Other OTC.
What sector is NNBP in?
Nanobac Pharmaceuticals, Incorporated (NNBP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nanobac Pharmaceuticals, Incorporated?
John Stanton is the chief executive officer of Nanobac Pharmaceuticals, Incorporated (NNBP).
Where is Nanobac Pharmaceuticals, Incorporated headquartered?
Nanobac Pharmaceuticals, Incorporated is headquartered in United States.
Does NNBP pay a dividend?
Nanobac Pharmaceuticals, Incorporated (NNBP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NNBP go public?
Nanobac Pharmaceuticals, Incorporated (NNBP) completed its initial public offering in 1994.